Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2

Human Mutation

Volumn 20, Issue 6, 2002, Pages 413-424

  Liede, Alexander ^a,b   Narod, Steven A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Asia; BRCA1; BRCA2; Breast cancer; China; Founder effect; Founder mutations; India; Iran; Japan; Ovarian cancer; Pakistan; Philippines; Singapore

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ASIA; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CULTURAL FACTOR; ETHNIC GROUP; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVIEW;

ASIA; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; MUTATION; OVARIAN NEOPLASMS;

EID: 0036450901     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10154     Document Type: Review

References (77)

1. Anglian Breast Cancer Study Group. 2000. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308.
2. Bar-Sade RB, Kruglikova A, Modan B, Gak E, Hirsh-Yechezkel G, Theodor L, Novikov I, Gershoni-Baruch R, Risel S, Papa MZ, Ben-Baruch G, Friedman E. 1998. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet 7:801-805.
3. Bhurgri Y, Bhurgri A, Hassan SH, Zaidi SH, Rahim A, Sankaranarayanan R, Parkin DM. 2000. Cancer incidence in Karachi, Pakistan: First results from Karachi Cancer Registry. Int J Cancer 85:325-329.
4. BIC. 2002. Breast Cancer Information Core Database. www.nhgri.nih.gov/Intramural_research/Lab_transfer/Bic/.
5. Chappuis PO, Hamel N, Paradis AJ, Deschenes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD. 2001. Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin Genet 59:418-423.
6. Claus EB, Schildkraut JM, Thompson WD, Risch NJ. 1996. The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324.
7. De Leon Matsuda ML, Liede A, Kwan E, Mapua CA, Cutiongco EMC, Tan A, Borg A, Narod SA. 2002. BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Intl J Cancer 98:596-603.
8. Elit L, Jack E, Kwan E, Baigal G, Narod S. 2001. A unique BRCA1 mutation identified in Mongolia. Int J Gynecol Cancer 11:241-243.
9. Ellis D, Greenman J, Hodgson S, McCall S, Lalloo F, Cameron J, Izatt L, Scott G, Jacobs C, Watts S, Chorley W, Perrett C, MacDermot K, Mohammed S, Evans G, Mathew CG. 2000. Low prevalence of BRCA1 mutations in early onset breast cancer without family history. J Med Genet 37:792-794.
10. Emi M, Matsushima M, Katagiri T, Yoshimoto M, Kasumi F, Yokota T, Nakata T, Miki Y, Nakamura Y. 1998. Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers. Jpn J Cancer Res 89:12-16.
11. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. 1994. Risks of cancer in BRCA1 mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692-695.
12. Fukutomi T, Ushijima T, Inoue R, Akashi-Tanaka S, Nanasawa T, Tsuda H. 1997. BRCA1 and BRCA2 germline mutations in Japanese with hereditary breast cancer families. Breast Cancer 4:256-258.
13. Garcia-Patino E, Gomendio B, Provencio M, Silva JM, Garcia JM, Espana P, Bonilla E 1998. Germ-line BRCA1 mutations in women with sporadic breast cancer: Clinical correlations. J Clin Oncol 16:115-120.
14. Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H. 2001. Germline BRCA1 mutations in Iranian women with breast cancer. Cancer Lett 165:87-94.
15. Healey CS, Dunning AM, Dawn Teare M, Chase D, Parker L, Burn J, Chang-Claude J, Mannermaa A, Kataja V, Huntsman DG, Pharoah PD, Luben RN, Easton DF, Ponder BA. 2000. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nature Genet 26:362-364.
16. Herrinton LJ, Stanford JL, Schwartz SM, Weiss NS. 1994. Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst 86:1336-1339.
17. Ho GH, Phang BH, Ng IS, Law HY, Soo KC, Ng EH. 2000. Novel germline BRCA1 mutations detected in women in Singapore who developed breast carcinoma before the age of 36 years. Cancer 89:811-816.
18. Hopper JL, Southley MC, Dite GS, Jolley DJ, Giles GG, McCredie MRE, Easton DF, Venter DJ. 1999. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741-747.
19. Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Moritoshi K, Noguchi S. 2001. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83-88.
20. Inoue R, Fukutomi T, Ushijima T, Matsumoto Y, Sugimura T, Nagao M. 1995. Germline mutation of BRCA1 in Japanese breast cancer families. Cancer Res 55:3521-3524.
21. Inoue R, Ushijima T, Fukutomi T, Fukami A, Sugimura H, Inoue S, Okonogi H, Sugimura T, Matsumoto Y, Nagao M. 1997. BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 74:199-204.
22. Jin F, Shu XO, Devesa SS, Zheng W, Blot WJ, Gao YT 1993. Incidence trends for cancers of the breast, ovary, and corpus uteri in urban Shanghai, 1972-89. Cancer Causes Control 4:355-360.
23. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB. 1996. High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56:3663-3665.
24. Kang HC, Kim I-J, Park J-H, Kwon H-J, Won Y-J, Heo SC, Lee S-Y, Kim K-H, Shin Y, Noh DY, Yang J-H, Park J-G. 2002. Germline mutations of the BRCA1 and BRCA2 genes in Korean breast and/or ovarian cancer families. Hum Mutat 20:235.
25. Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Iwase T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y. 1996. Mutations in the BRCA1 gene in Japanese breast cancer patients. Hum Mutat 7:334-339.
26. Katagiri T, Kasumi F, Yoshimoto M, Nomizu T, Asaishi K, Abe R, Tsuchiya A, Sugano M, Takai S, Yoneda M, Fukutomi T, Nanba K, Makita M, Okazaki H, Hirata K, Okazaki M, Furutsuma Y, Morishita Y, Iino Y, Karino T, Ayabe H, Hara S, Kajiwara T, Houga S, Miki Y. 1998. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J Hum Genet 43:42-48.
27. Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H. 2000. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 16:88-89.
28. Khoo US, Chan KY, Cheung AN, Xue WC, Shen DH, Fung KY, Ngan HY, Choy KW, Pang CP, Poon CS, Poon AY, Ozcelik H. 2002. Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19:307-308.
29. Kijima G, Murakami Y, Ohuchi N, Satomi S, Sekiya T. 1998. Nonsense mutation at codon 63 of the BRCA1 gene in Japanese breast cancer patients. Jpn J Cancer Res 89:837-841.
30. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. 1996. BRCA1 mutations in a population-based sample of young women with breast cancer. New Engl J Med 334:137-142.
31. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. 1997. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: Frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60:1059-1067.
32. Li SS, Tseng HM, Yang TP, Liu CH, Teng SJ, Huang HW, Chen LM, Kao HW, Chen JH, Tseng JN, Chen A, Hou MF, Huang TJ, Chang HT, Mok KT, Tsai JH. 1999. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104:201-204.
33. Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA. 2002. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71:595-606.
34. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. 2001. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93:1215-1223.
35. Malone KE, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. 1998. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279:922-929.
36. Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA. 2000. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393-1402.
37. Matsushima M, Kobayashi K, Emi M, Saito H, Saito J, Suzumori K, Nakamura Y. 1995. Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: Four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 4:1953-1956.
38. Modan B, Hartge P, Hirsh-Yechezkel G, Chetrit A, Lubin F, Beller U, Ben-Baruch G, Fishman A, Menczer J, Ebbers SM, Tucker MA, Wacholder S, Struewing JP, Friedman E, Piura B. 2001. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 345:235-240.
39. Moslehi R, Soledhin F, Malik I, Narod S. 1998. Analysis of BRCA1 mutations in a Pakistani family with hereditary breast and ovarian cancer syndrome. Am J Med Genet 78:386-387.
40. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. 2000. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259-1272.
41. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE. 1996. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet 58:271-280.
42. Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King M-C. 1998. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915-921.
43. Noguchi S, Kasugai T, Miki Y, Fukutomi T, Emi M, Nomizu T. 1999. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women. Cancer 85:2200-2205.
44. Papelard H, de Bock GH, van Eijk R, Vliet Vlieland TP, Cornelisse CJ, Devilee P, Tollenaar RA. 2000. Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer 83:719-724.
45. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. 1997. Cancer Incidence in Five Continents, vol VII. Lyon: IARC. Scientific Publication No. 143.
46. Parkin DM, Pisani P, Gibson LJ, Esteban DB, Ngelangel CA, Laudico AV. 2000. Screening for Cancer of the Breast in the Philippines. IARC Biennial Report, 1998/1999. Lyon: IARC. p 129-130.
47. Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo CI, Saunders GF, Goldgar D, Lenoir GM. 2002. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat, in press.
48. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR. 1999. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949.
49. Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JLA, Fan I, Wong B, Narod SA. 2001. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700-710.
50. Rubin SC, Blackwood MA, Bandera C, Behbakht K, Benjamin I, Rebbeck TR, Boyd J. 1998. BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: Relationship to family history and implications for genetic testing. Am J Obstet Gynecol 178:670-677.
51. Sarantaus L, Vahteristo P, Bloom E, Tamminen A, Unkila-Kallio L, Butzow R, Nevanlinna H. 2001. BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients. Eur J Hum Genet 9:424-430.
52. Saxena S, Szabo C, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar D, Bhatanager D. 2002. BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat, in press.
53. Schehl CM, Ostrander GK. 1997. Identification of BRCA1 germline mutation, 797delAA, in a Japanese breast-ovarian cancer patient. J Natl Cancer Inst 89:1547-1548.
54. Sekine M, Nagata H, Tsuji S, Hirai Y, Fujimoto S, Hatae M, Kobayashi I, Fujii T, Nagata I, Ushijima K, Obata K, Suzuki M, Yoshinaga M, Umesaki N, Satoh S, Enomoto T, Motoyama S, Tanaka K. 2001. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7:3144-3150.
55. Shu XO, Brinton LA, Gao YT, Yuan JM. 1989. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 49:3670-3674.
56. Smith SA, Richards WE, Caito K, Hanjani P, Markman M, DeGeest K, Gallion HH. 2001. BRCA1 germline mutations and polymorphisms in a clinic-based series of ovarian cancer cases: A Gynecologic Oncology Group study. Gynecol Oncol 83:586-592.
57. Sng JH, Chang J, Feroze F, Rahman N, Tan W, Lim S, Lehnert M, van der Pool S, Wong J. 2000. The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 82:538-542.
58. Southey MC, Tesoriero AA, Andersen CR, Jennings KM, Brown SM, Dite GS, Jenkins MA, Osborne RH, Maskiell JA, Porter L, Giles GG, McCredie MR, Hopper JL, Venter DJ. 1999. BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer. Br J Cancer 79:34-39.
59. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, Easton D, Ponder BA. 1997. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125-1130.
60. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408.
61. Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, Sarantaus L, Holli K, Blomqvist C, Kallioniemi OP, Kainu T, Nevanlinna H. 2000. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92:1529-1531.
62. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rebane BA, Cardonick A, Mikuta JJ, Rubin SC, Boyd J. 1995. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998-3002.
63. Takahashi H, Chiu HC, Bandera CA, Behbakht K, Liu PC, Couch FJ, Weber BL, LiVolsi VA, Furusato M, Rebane BA, Cardonick A, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC, Boyd J. 1996. Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res 56:2738-2741.
64. Takano M, Aida H, Tsuneki I, Takakuwa K, Hasegawa I, Tanaka H, Saito M, Tsuji S, Sonoda T, Hatae M, Chen JT, Takahashi K, Hasegawa K, Toyoda N, Saito N, Yakushiji M, Araki T, Tanaka K. 1997. Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan. Jpn J Cancer Res 88:407-413.
65. Tang NLS, Pang C-P, Yeo W, Choy K-W, Lam PK, Suen M, Law LK, King WWK, Johnson P, Hjelm M. 1999. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst 91:882-885.
66. Tang NL, Choy KW, Pang CP, Yeo W, Johnson PJ. 2001. Prevalence of breast cancer predisposition gene mutations in Chinese women and guidelines for genetic testing. Clin Chim Acta 313:179-185.
67. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjord JE. 1997. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60:1079-1084.
68. Tobias DH, Eng C, McCurdy LD, Kalir T, Mandelli J, Dottino PR, Cohen CJ. 2000. Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 78:148-151.
69. Tonin PN, Perret C, Lambert JA, Paradis AJ, Kantemiroff T, Benoit MH, Martin G, Foulkes WD, Ghadirian P. 2001. Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history. Int J Cancer 95:189-193.
70. Usmani K, Khanum A, Afzal H, Ahmad N. 1996. Breast cancer in Pakistani women. J Environ Pathol Toxicol Oncol 15:251-253.
71. Van Der Looij M, Szabo C, Besznyak I, Liszka G, Csokay B, Pulay T, Toth J, Devilee P, King MC, Olah E. 2000. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86:737-740.
72. Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. 1999. Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241-1247.
73. Xu CF, Chambers JA, Nicolai H, Brown MA, Hujeirat Y, Mohammed S, Hodgson S, Kelsell DP, Spurr NK, Bishop DT, Solomon E. 1997. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families. Genes Chromosomes Cancer 18:102-110.
74. Yamashita Y, Sagawa T, Fujimoto T, Sugawara T, Yamada H, Hoshi N, Sakuragi N, Ishioka C, Fujimoto S. 1999. BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening. Breast Cancer Res Treat 58:11-17.
75. Yassaee VR, Zeinali S, Harirchi I, Jarvandi S, Mohagheghi MA, Hornby DP, Dalton A. 2002. Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res 4:R6.
76. Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H. 2000. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. Br J Cancer 83:737-742.
77. Zhi X, Szabo C, Chopin S, Suter N, Wang Q-S, Ostrander EA, Sinilnikova OM, Gilbert M. Lenoir GM, Goldgar D, Shi Y-R. 2002. BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat, in press.